Inovio Biomedical Income Statement
View: Annual | Quarterly
This data is provided as per license from EDGAR Online
| Dec 07 | Dec 06 | Dec 05 | |
|---|---|---|---|
| Revenue | 4.8 | 3.5 | 5.5 |
| Cost of Goods Sold | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| Gross Profit Margin | 0.0% | 0.0% | 0.0% |
| SG&A Expense | 19.8 | 15.9 | 20.2 |
| Depreciation & Amortization | 0.9 | 0.9 | 0.8 |
| Operating Income | (15.9) | (13.4) | (15.5) |
| Operating Margin | -- | -- | -- |
| Nonoperating Income | 4.7 | 0.9 | 0.2 |
| Nonoperating Expenses | -- | -- | -- |
| Income Before Taxes | (11.2) | (12.5) | (15.3) |
| Income Taxes | -- | -- | -- |
| Net Income After Taxes | (11.2) | (12.5) | (15.3) |
| Continuing Operations | (11.2) | (12.5) | (15.3) |
| Discontinued Operations | -- | -- | -- |
| Total Operations | (11.2) | (12.5) | (15.3) |
| Total Net Income | (11.2) | (12.5) | (15.3) |
| Net Profit Margin | -- | -- | -- |
| Diluted EPS from Total Net Income ($) | (0.27) | (0.46) | (1.39) |
| Dividends per Share | -- | -- | -- |
This data is provided as per license from EDGAR Online
